TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35403949

Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 24

Group type: COMPARATOR
Intervention: IDegAsp
Number of subjects: 24
Study: 33585943

Group type: EXPERIMENTAL
Intervention: Robotic balance training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional balance training
Number of subjects: 22
Study: 33305551

Group type: COMPARATOR
Intervention: Resistance Training (RT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Dynamic Training (DT)
Number of subjects: 48
Study: 32090585

Group type: EXPERIMENTAL
Intervention: Nutritional advice and nutritional supplementation for 12 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 76
Study: 36242868

Group type: EXPERIMENTAL
Intervention: Emergency cervical cerclage (ECC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 34
Study: 32495016

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical resection (LRR)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Open abdominal radical hysterectomy
Number of subjects: 168
Study: 36261917

Group type: EXPERIMENTAL
Intervention: STUDYCoach online intervention (used over three consecutive weeks)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: STUDYCoach online intervention
Number of subjects: 209

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 209
Study: 33619316

Group type: EXPERIMENTAL
Intervention: Genetically higher education level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher education level adjusted for intelligence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher education level
Number of subjects: 0
Study: 32102646

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate diluted in 5% dextrose (D5W)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Participants using a clue
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Participants not using a clue
Number of subjects: 60
Study: 36384493

Group type: EXPERIMENTAL
Intervention: Standard medical therapy combined with NBP treatment (NBP 200 mg, three times per day for 24 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard medical therapy
Number of subjects: 0
Study: 32090511

Group type: EXPERIMENTAL
Intervention: HTGW+ individuals
Number of subjects: 6874

Group type: COMPARATOR
Intervention: HTGW- individuals
Number of subjects: 6874
Study: 35199250

Group type: EXPERIMENTAL
Intervention: Indocyanine green injection with the da Vinci Xi‐equipped Firefly system
Number of subjects: 55
Study: 34322967

Group type: EXPERIMENTAL
Intervention: Insulin degludec U100
Number of subjects: 498

Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 498
Study: 35123236

Group type: EXPERIMENTAL
Intervention: Manual Rapid Infuser
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Push-pull with 60 mL syringe
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Push-pull with 10 mL syringe
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Hand pump with pressure bag
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Hand pump without pressure bag
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Pressure bag
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Gravity
Number of subjects: 240
Study: 34285664

Group type: EXPERIMENTAL
Intervention: Micromedex
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Micromedex with Watson
Number of subjects: 162

Group type: COMPARATOR
Intervention: Google
Number of subjects: 162
Study: 34637559

Group type: EXPERIMENTAL
Intervention: BFR resistance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-exercising patients)
Number of subjects: 0
Study: 33601395

Group type: EXPERIMENTAL
Intervention: MCS (conventional stockings)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: MCS-SkC (compression stockings with integrated care emulsion)
Number of subjects: 33
Study: 36107412

Group type: EXPERIMENTAL
Intervention: Total Intravenous Anesthesia (TIVA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Inhalational Anesthesia (INH)
Number of subjects: 78
Study: 34324724

Group type: EXPERIMENTAL
Intervention: ALA-PDT + IPL
Number of subjects: 20

Group type: COMPARATOR
Intervention: ALA-PDT only
Number of subjects: 20
Study: 33664158

Group type: EXPERIMENTAL
Intervention: Music Attention Control Training (MACT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention Process Training (APT)
Number of subjects: 0
Study: 34240627

Group type: EXPERIMENTAL
Intervention: Active tDCS for 6 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham tDCS for 6 months
Number of subjects: 100
Study: 33268967

Group type: EXPERIMENTAL
Intervention: WNJT (n = 147)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Nasal cannula (n = 144)
Number of subjects: 291
Study: 36052536

Group type: EXPERIMENTAL
Intervention: Enfortumab vedotin (EV) 1.25 mg/kg on Days 1, 8, and 15 for 28-day cycles
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard chemotherapy (SC; docetaxel or paclitaxel) on Day 1 of each 21-day cycle
Number of subjects: 86
Study: 34265066

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 33033049

Group type: EXPERIMENTAL
Intervention: Healthy intervertebral discs (Pfirrmann grade ≤2)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Degenerated intervertebral discs (Pfirrmann grade ≥3)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Intrasubject variability for healthy intervertebral discs
Number of subjects: 101

Group type: COMPARATOR
Intervention: All segment-matched healthy discs as references
Number of subjects: 101
Study: 33104373

Group type: EXPERIMENTAL
Intervention: Personal resources training intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 102
Study: 34087466

Group type: EXPERIMENTAL
Intervention: ICG‐aPDT
Number of subjects: 50
Study: 33006966

Group type: EXPERIMENTAL
Intervention: High perceived criticism from romantic partners
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: High perceived criticism from parents
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: High perceived criticism from friends
Number of subjects: 49

Group type: COMPARATOR
Intervention: Low perceived criticism
Number of subjects: 49
Study: 34688923

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Present-centered group therapy (control)
Number of subjects: 98
Study: 32538006

Group type: EXPERIMENTAL
Intervention: Nape cluster acupuncture combined with swallowing function training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Swallowing function training (control group)
Number of subjects: 60
Study: 34767474

Group type: EXPERIMENTAL
Intervention: Oncology nurse-led primary palliative care intervention (CONNECT)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 457
Study: 33064207

Group type: EXPERIMENTAL
Intervention: Novel herbal toothpaste containing clove, aloe vera, amla, neem, tulsi, honey, 0.96% zinc, and 0.76% SMFP (1000 ppm F) in a calcium carbonate base.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Fluoride toothpaste containing 0.76% SMFP (1000 ppm F) in a calcium carbonate base (Colgate Cavity Protection).
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Novel herbal toothpaste
Number of subjects: 70
Study: 32320285

Group type: EXPERIMENTAL
Intervention: 45‐kHz frequency at 1 mm
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1‐MHz frequency at 1 mm
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 45‐kHz frequency at 4 mm
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1‐MHz frequency at 4 mm
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both frequencies
Number of subjects: 40
Study: 96008295

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) at a dose of 5MU daily or 10 MU three times a week for 3 to 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapies including interferon alpha with Ara-AMP, acyclovir, didoxynucleoside or interferon-gamma
Number of subjects: 0
Study: 35715644

Group type: EXPERIMENTAL
Intervention: Astodrimer sodium nasal spray (1%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33426570

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid gel (HAG)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Fat
Number of subjects: 150
Study: 33408857

Group type: EXPERIMENTAL
Intervention: NPWT with normal saline instillation (NPWTi)
Number of subjects: 48

Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 48
Study: 33248578

Group type: EXPERIMENTAL
Intervention: Protease supplementation (20,000U/kg)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Low-protein diets (13.5% CP)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Interaction of low-protein diets and protease supplementation
Number of subjects: 576
Study: 34352588

Group type: EXPERIMENTAL
Intervention: EP prenylflavonoid extract (740 mg daily)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 32888702

Group type: EXPERIMENTAL
Intervention: Physical Exercise Program (PEP) for 12 weeks
Number of subjects: 20
Study: 36379585

Group type: EXPERIMENTAL
Intervention: Add-on imeglimin 1000 mg two times per day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Metformin dose escalation
Number of subjects: 70
Study: 33300818

Group type: EXPERIMENTAL
Intervention: Montelukast formulations
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Processed plasma samples exposed to fluorescent light for 24h
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Unprocessed plasma samples
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Standard calibration curve
Number of subjects: 24
Study: 32167260

Group type: EXPERIMENTAL
Intervention: Ganglion cell complex thickness-to-total retinal thickness ratio (G/T ratio)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Average RNFLT, average GCC, total retinal thickness
Number of subjects: 86

Group type: COMPARATOR
Intervention: Healthy group
Number of subjects: 86
Study: 35417758

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate, High-Protein (LC/HP) diet for 8 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (usual diet) for 8 weeks
Number of subjects: 19
Study: 34047904

Group type: EXPERIMENTAL
Intervention: Self-acupressure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0
Study: 32123969

Group type: EXPERIMENTAL
Intervention: 177Lu-Dotatate (every 8 weeks, four cycles) plus octreotide long-acting release (LAR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: octreotide LAR 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 177Lu-Dotatate
Number of subjects: 0
Study: 35698187

Group type: EXPERIMENTAL
Intervention: Post Isometric Relaxation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Myofascial Release Therapy
Number of subjects: 60
Study: 35057905

Group type: EXPERIMENTAL
Intervention: Intravaginal lactic acid gel (5 ml once daily for 7 days)
Number of subjects: 518

Group type: COMPARATOR
Intervention: Oral metronidazole (400 mg twice daily for 7 days)
Number of subjects: 518
Study: 34358521

Group type: EXPERIMENTAL
Intervention: Continuous suture technique
Number of subjects: 421

Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 421
Study: 35484106

Group type: EXPERIMENTAL
Intervention: HARPdoc (Hypoglycaemia Awareness Restoration Programme)
Number of subjects: 99

Group type: COMPARATOR
Intervention: BGAT (Blood Glucose Awareness Training)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: HARPdoc
Number of subjects: 99
Study: 33771685

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33100049

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control (<120 mm Hg)
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard systolic blood pressure control (<140 mm Hg)
Number of subjects: 9361
Study: 36111911

Group type: EXPERIMENTAL
Intervention: Radon baths (general baths at a temperature of 34‐36°C, duration 10‐15 minutes, every other day, No. 10)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ordinary tap water baths (same regimen as study group)
Number of subjects: 40
Study: 32065032

Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Number of subjects: 13
Study: 35724774

Group type: EXPERIMENTAL
Intervention: 30 mg avasopasem
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 90 mg avasopasem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Xerostomia and trismus data
Number of subjects: 0
Study: 33726830

Group type: EXPERIMENTAL
Intervention: ASPIRE intervention (a four-session blended multi-component counselling intervention)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ASPIRE intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison condition (not specified)
Number of subjects: 100
Study: 33415994

Group type: EXPERIMENTAL
Intervention: Participants reporting elder abuse or neglect against their elderly parents
Number of subjects: 7466

Group type: EXPERIMENTAL
Intervention: Instances of abuse and neglect reported by participants
Number of subjects: 7466

Group type: EXPERIMENTAL
Intervention: Participants reporting multiple types of abuse and neglect
Number of subjects: 7466

Group type: EXPERIMENTAL
Intervention: Co-occurrence of elder abuse within elderly couples
Number of subjects: 7466

Group type: EXPERIMENTAL
Intervention: Association of elder abuse and neglect with socioeconomic and contextual factors
Number of subjects: 7466
Study: 33434727

Group type: EXPERIMENTAL
Intervention: Mindfulness-based group therapy (MBGT) + Treatment-as-usual (TAU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 40
Study: 36384950

Group type: EXPERIMENTAL
Intervention: Community-based education and peer support programme led by women's self-help group members; assistance in daily hypertension management, social and emotional support, referral to primary healthcare system.
Number of subjects: 1952

Group type: COMPARATOR
Intervention: Standard of care (control arm).
Number of subjects: 1952
Study: 32112593

Group type: EXPERIMENTAL
Intervention: Media-based recruitment
Number of subjects: 168

Group type: COMPARATOR
Intervention: Face-to-face recruitment
Number of subjects: 168
Study: 35197411

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: High aerobic with low resistance training (HALRT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: High resistance with low aerobic training (HRLAT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control
Number of subjects: 85
Study: 33207300

Group type: EXPERIMENTAL
Intervention: Stroke awareness assessment through a questionnaire
Number of subjects: 144
Study: 32315289

Group type: EXPERIMENTAL
Intervention: Intragastric infusion of glucose
Number of subjects: 76

Group type: COMPARATOR
Intervention: Intragastric infusion of water
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Baseline levels of peripheral appetite hormones
Number of subjects: 76
Study: 616543714

Group type: EXPERIMENTAL
Intervention: Pharmacy student-created podcasts
Number of subjects: 29
Study: 34281042

Group type: EXPERIMENTAL
Intervention: CPR_PPE
Number of subjects: 20

Group type: COMPARATOR
Intervention: CPR_control
Number of subjects: 20
Study: 33048034

Group type: EXPERIMENTAL
Intervention: Arterial transit artifacts (ATAs) in participants with greater than 70% stenosis (16 of 28 patients)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Degree of stenosis (≥70% vs <70%)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Intraplaque hemorrhage (IPH) presence
Number of subjects: 44

Group type: COMPARATOR
Intervention: Plaque surface structure (irregular/ulcerated vs smooth)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Severity of arterial transit artifacts (ATAs)
Number of subjects: 44
Study: 34049538

Group type: EXPERIMENTAL
Intervention: New two-year residency program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional one-year family medicine residency program
Number of subjects: 0
Study: 35380374

Group type: EXPERIMENTAL
Intervention: ON-SXB 6 g
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: ON-SXB 7.5 g
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: ON-SXB 9 g
Number of subjects: 190
Study: 33515859

Group type: EXPERIMENTAL
Intervention: Gymnastics program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 50
Study: 32022679

Group type: EXPERIMENTAL
Intervention: SC+CBSC
Number of subjects: 250

Group type: COMPARATOR
Intervention: SC
Number of subjects: 250
Study: 36216727

Group type: EXPERIMENTAL
Intervention: 200 μg of remifentanil dissolved in 25 ml of saline
Number of subjects: 60

Group type: COMPARATOR
Intervention: 25 ml of intra‐articular normal saline
Number of subjects: 60
Study: 34126097

Group type: EXPERIMENTAL
Intervention: Superficial needling acupuncture
Number of subjects: 86

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 86

Group type: COMPARATOR
Intervention: Difference between acupuncture and sham
Number of subjects: 86

Group type: COMPARATOR
Intervention: Difference between groups at week 10
Number of subjects: 86

Group type: COMPARATOR
Intervention: Western Ontario and McMaster Universities Osteoarthritis Index
Number of subjects: 86

Group type: COMPARATOR
Intervention: 36-Item Short Form Health Survey
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 86
Study: 36316939

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine-based rehabilitation nursing combined with scalp acupuncture (TCMRN + SA)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Traditional Chinese medicine-based rehabilitation nursing (TCMRN)
Number of subjects: 102
Study: 35677618

Group type: EXPERIMENTAL
Intervention: Siddha medicine preparation (Nochi Kudineer Chooranam 5 gm, Mahasudarsan Chooranam 3 gm, Adathodai Manapagu 10 ml, Omatheeneer 10 ml, Maldevi chenduram 100 mg with honey) for 7 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study: 32058555

Group type: EXPERIMENTAL
Intervention: PanCan-1b model
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: PanCan-2b model
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: PanCan-MD model
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: PanCan-VOL model
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: UK Lung Cancer Screening trial model
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: Mayo Clinic model
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: Peking University People's Hospital model
Number of subjects: 1159

Group type: EXPERIMENTAL
Intervention: Department of Veterans Affairs model
Number of subjects: 1159
Study: 35973732

Group type: EXPERIMENTAL
Intervention: Lower (worse) secretion scores at baseline
Number of subjects: 2089

Group type: EXPERIMENTAL
Intervention: Lower secretion score
Number of subjects: 2089
Study: 34653721

Group type: EXPERIMENTAL
Intervention: Local Anesthetic Injection (LAI)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane Block (TAPB)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intraperitoneal Local Anesthetic Injection (IPLA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no local anesthetic)
Number of subjects: 160
Study: 32601985

Group type: COMPARATOR
Intervention: Placebo–placebo
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo–propranolol
Number of subjects: 161

Group type: COMPARATOR
Intervention: Dexamethasone–placebo
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Dexamethasone–propranolol
Number of subjects: 161
Study: 35404295

Group type: EXPERIMENTAL
Intervention: Auditory processing speed training (40 hours over 13 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Auditory processing speed training
Number of subjects: 18
Study: 34862871

Group type: EXPERIMENTAL
Intervention: Bevacizumab (Group I)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Apatinib (Group II)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Recombinant human endostatin (Group III)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no targeted drug)
Number of subjects: 200
Study: 35587019

Group type: EXPERIMENTAL
Intervention: Prolonged use of aprepitant (PA; 6‐day aprepitant)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard use of aprepitant (SA; 3‐day aprepitant)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (C; patients who rejected aprepitant)
Number of subjects: 0
Study: 33781388

Group type: EXPERIMENTAL
Intervention: PDCA management of central venous catheter
Number of subjects: 244

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 244
Study: 33582682

Group type: EXPERIMENTAL
Intervention: Fexofenadine (N=36)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Levocetrizine (N=37)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Desloratadine (N=29)
Number of subjects: 102
Study: 35313949

Group type: EXPERIMENTAL
Intervention: treatment-as-usual + AppBM
Number of subjects: 336

Group type: COMPARATOR
Intervention: treatment-as-usual + Sham
Number of subjects: 336

Group type: COMPARATOR
Intervention: treatment-as-usual only
Number of subjects: 336
Study: 35533225

Group type: EXPERIMENTAL
Intervention: Fluoride Varnish (FV) applied at three points
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified what the control was)
Number of subjects: 0
Study: 34590936

Group type: EXPERIMENTAL
Intervention: Complete visual occlusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lower visual field visual occlusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal vision
Number of subjects: 60
Study: 35277340

Group type: EXPERIMENTAL
Intervention: Lidocaine plus paracetamol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lidocaine plus morphine (control)
Number of subjects: 0
Study: 33693920

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum iron status
Number of subjects: 4036

Group type: EXPERIMENTAL
Intervention: Log-transformed ferritin
Number of subjects: 4036

Group type: EXPERIMENTAL
Intervention: Transferrin saturation
Number of subjects: 4036

Group type: EXPERIMENTAL
Intervention: Transferrin
Number of subjects: 4036